trending Market Intelligence /marketintelligence/en/news-insights/trending/KcSc8NeZBT8UbkTuVYYHtQ2 content esgSubNav
In This List

Bellus Health to undertake 1-for-3.6 share consolidation

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bellus Health to undertake 1-for-3.6 share consolidation

Bellus Health Inc. will consolidate its common shares on a 1-for-3.6 basis, effective Aug. 19.

The move will reduce the company's outstanding common shares from about 159.1 million to about 44.2 million.

The Quebec-based biopharmaceutical company expects trading in its post-consolidated shares to begin by Aug. 19 on the Toronto Stock Exchange under existing ticker BLU.

No fractional common shares will be issued in connection with the consolidation that was approved by the company's shareholders May 8.

Bellus Health's transfer agent, Computershare Investor Services, would act as the exchange agent for the consolidation.